Mini review: STING activation during non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases serving as a major threat to human health. While the pathogenesis of NAFLD is multi-factorial, inflammation is considered a critical factor driving the development and progression of NAFLD phenotype, including liver...

Full description

Bibliographic Details
Main Authors: Honggui Li, Xinlei Guo, Eduardo Aquino, Chaodong Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1139339/full
_version_ 1811162617793740800
author Honggui Li
Xinlei Guo
Eduardo Aquino
Chaodong Wu
author_facet Honggui Li
Xinlei Guo
Eduardo Aquino
Chaodong Wu
author_sort Honggui Li
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases serving as a major threat to human health. While the pathogenesis of NAFLD is multi-factorial, inflammation is considered a critical factor driving the development and progression of NAFLD phenotype, including liver fibrosis. As an essential mediator of innate immunity, stimulator of interferon genes (STING) functions to promote anti-viral immunity. Accumulating evidence also indicates that STING functions to promote the proinflammatory activation of several types of liver cells, especially macrophages/Kupffer cells, in a manner independent of interferon production. Over the past several years, a significant body of literature has validated a detrimental role for STING in regulating the pathogenesis of hepatic steatosis and inflammation. In particular, the STING in macrophages/Kupffer cells has attracted much attention due to its importance in not only enhancing macrophage proinflammatory activation, but also generating macrophage-derived mediators to increase hepatocyte fat deposition and proinflammatory responses, and to activate hepatic stellate cell fibrogenic activation. Both intracellular and extracellular signals are participating in STING activation in macrophages, thereby critically contributing to NAFLD phenotype. This mini review summarizes recent advances on how STING is activated in macrophages in the context of NAFLD pathophysiology.
first_indexed 2024-04-10T06:32:16Z
format Article
id doaj.art-c873f605aa2845bea2563fd5d5aa4baa
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-04-10T06:32:16Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-c873f605aa2845bea2563fd5d5aa4baa2023-03-01T06:50:52ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-03-011010.3389/fnut.2023.11393391139339Mini review: STING activation during non-alcoholic fatty liver diseaseHonggui LiXinlei GuoEduardo AquinoChaodong WuNon-alcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases serving as a major threat to human health. While the pathogenesis of NAFLD is multi-factorial, inflammation is considered a critical factor driving the development and progression of NAFLD phenotype, including liver fibrosis. As an essential mediator of innate immunity, stimulator of interferon genes (STING) functions to promote anti-viral immunity. Accumulating evidence also indicates that STING functions to promote the proinflammatory activation of several types of liver cells, especially macrophages/Kupffer cells, in a manner independent of interferon production. Over the past several years, a significant body of literature has validated a detrimental role for STING in regulating the pathogenesis of hepatic steatosis and inflammation. In particular, the STING in macrophages/Kupffer cells has attracted much attention due to its importance in not only enhancing macrophage proinflammatory activation, but also generating macrophage-derived mediators to increase hepatocyte fat deposition and proinflammatory responses, and to activate hepatic stellate cell fibrogenic activation. Both intracellular and extracellular signals are participating in STING activation in macrophages, thereby critically contributing to NAFLD phenotype. This mini review summarizes recent advances on how STING is activated in macrophages in the context of NAFLD pathophysiology.https://www.frontiersin.org/articles/10.3389/fnut.2023.1139339/fullnon-alcoholic fatty liver diseaseliver fibrosisinflammationstimulator of interferon genesmacrophage
spellingShingle Honggui Li
Xinlei Guo
Eduardo Aquino
Chaodong Wu
Mini review: STING activation during non-alcoholic fatty liver disease
Frontiers in Nutrition
non-alcoholic fatty liver disease
liver fibrosis
inflammation
stimulator of interferon genes
macrophage
title Mini review: STING activation during non-alcoholic fatty liver disease
title_full Mini review: STING activation during non-alcoholic fatty liver disease
title_fullStr Mini review: STING activation during non-alcoholic fatty liver disease
title_full_unstemmed Mini review: STING activation during non-alcoholic fatty liver disease
title_short Mini review: STING activation during non-alcoholic fatty liver disease
title_sort mini review sting activation during non alcoholic fatty liver disease
topic non-alcoholic fatty liver disease
liver fibrosis
inflammation
stimulator of interferon genes
macrophage
url https://www.frontiersin.org/articles/10.3389/fnut.2023.1139339/full
work_keys_str_mv AT hongguili minireviewstingactivationduringnonalcoholicfattyliverdisease
AT xinleiguo minireviewstingactivationduringnonalcoholicfattyliverdisease
AT eduardoaquino minireviewstingactivationduringnonalcoholicfattyliverdisease
AT chaodongwu minireviewstingactivationduringnonalcoholicfattyliverdisease